Particle.news
Capcom Analyst Expectations Cost-Cutting Measures Sales Growth Negative Cash Flow Sales Projections Adjusted Profit Outlook Quarterly Performance Revenue Growth Shareholder Returns Humana Earnings Forecast Revenue Projections Revenue Variance Market Uncertainty Adjusted Earnings Market Performance Share Buybacks
Despite beating Q1 earnings expectations, Merck adjusted its annual EPS guidance downward due to $200 million in tariff costs and a one-time charge tied to a licensing deal.
